logo
  

MorphoSys Turns To Profit In Q4

MorphoSys AG (MOR) reported that its net profit for the fourth quarter 2022 was 329.4 million euros compared to a net loss of 381.0 million euros in the prior year. The net profit in the latest-quarter was driven mainly by the recognition of finance income triggered by the reduction in financial liabilities from collaborations.

Operating loss narrowed to 68.4 million euros from the prior year's 325.0 million euros, primarily driven by the impairment of goodwill amounting to 230.7 million euros recognized in the prior year.

Total revenues for the fourth quarter rose to 81.6 million euros from the prior year's 52.9 million euros, reflecting higher revenues from the global licensing agreement with Novartis executed in the fourth quarter 2022.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
RELATED NEWS
Follow RTT